A Phase II Study Of Tirapazamine (NSC-130181)/Cisplatin/Etoposide And Concurrent Thoracic Radiotherapy For Limited Stage Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Tirapazamine (Primary) ; Cisplatin; Etoposide
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 18 Jul 2012 Actual patient number changed from 85 to 72 as reported by ClinicalTrials.gov.
- 08 Jun 2011 Actual end date changed from Jan 2009 to Aug 2009 as reported by ClinicalTrials.gov.